EMAIL DETAILS
SUBJECT:
Don't cry for the end of Peronism
PRI: NORMAL
FROM:
N
noreply@mail.bloombergview.com
DATE:
2017-11-30 10:02:01
MSG_ID:
<20171130050201.11424930.27375@sailthru.com>
RECIPIENTS:
TO:
H
hbiden@rosemontseneca.com
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Share the View@media only screen and (max-device-width: 480px) {
body {
padding: 10px !important;
}
.one-column p,
.one-column li {
font-size: 19px !important;
line-height: 29px !important;
}
}A daily digest of opinions and analysisArgentina Leaves Evita BehindPeronism's old populist playbook no longer works in a changing country, as the business-friendly Cambiemos coalition's electoral victories have shown. Shannon O'Neil takes stock of the big shifts taking place in Argentina's economy and society.Brexit Vexes Ireland, So Ireland Vexes the U.K.No EU country has more to lose from Brexit than the U.K., "but Ireland comes a close second," Therese Raphael notes — and the two neighbors' trade and border politics are snarling Britain's divorce proceedings with Europe. Keep Churches' Tax Break, With Strings AttachedAmerican houses of worship shouldn't be allowed to engage in politics. Also: That rule shouldn't be too strictly enforced. Megan McArdle considers the future of the rule that requires tax-exempt churches to keep quiet about elections.It's a War for Truth, and This Newspaper Knows ItWashington Post editor Marty Baron likes to say, "We're not at war, we're at work" — but fake-news fraudsters really have declared war on journalism, and pacifism is not an option. Francis Wilkinson says the WaPo's exposure of a right-wing hoaxer was a necessary act of self-defense in the Trump era.Ritholtz's ReadsActive vs. passive vs. Amazon et al. (CFA Institute)America's "retail apocalypse" is really just beginning (Bloomberg) How guerrilla tactics toppled RenTech's Robert Mercer (Institutional Investor)(Read Barry Ritholtz's full daily news roundup here.) Bloomberg GadflyIt's "Today" without Matt Lauer, and that's fineChipotle's next CEO must do what its founder couldn'tTrump's HHS pick might not be totally pharma-friendly(Read more from BV's sister site for fast business commentary.)Bloomberg L.P. ● 731 Lexington Avenue, New York, NY 10022Web ● Facebook ● TwitterFeedback ● Unsubscribe
If you believe this has been sent to you in error, please click <http://link.mail.bloombergbusiness.com/oc/57d81a102ddf9c08613460d76svj6.l4f/836685ce> to safely unsubscrib
METADATA:
THREAD:
INDEX:
AdhhnorsKWaVlBzpQvWtuyEAMNFRoA==